Zfhep Activators
ZFHEP Activators are a diverse collection of compounds that enhance the functional activity of ZFHEP through various mechanisms related to transcriptional regulation and epigenetic modification. Zinc Sulfate, by providing zinc ions, directly augments ZFHEP's DNA-binding capacity, a fundamental aspect of its role in transcriptional regulation. Retinoic Acid and Curcumin, through their influence on gene expression and various signaling pathways, respectively, create an environment conducive to the enhancement of ZFHEP's transcriptional activities, especially in processes like cell differentiation. Epigenetic modifiers such as Trichostatin A and 5-Azacytidine significantly impact ZFHEP's function;
Trichostatin A, by altering chromatin structure, and 5-Azacytidine, by changing DNA methylation patterns, both enhance the accessibility of ZFHEP to genomic DNA, thus promoting its regulatory effects on gene expression. Furthermore, Forskolin raises cAMP levels, indirectly influencing ZFHEP's activity by affecting cAMP-responsive elements and transcription factors that may interact with ZFHEP in gene regulation.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Zinc sulfate provides zinc ions, essential cofactors for ZFHEP function. Zinc ions directly enhance ZFHEP's DNA-binding ability, crucial for its role in transcriptional regulation. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic Acid influences gene expression and transcriptional regulation. It can enhance ZFHEP activity by modulating the transcriptional environment where ZFHEP operates, particularly in differentiation pathways. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A, a histone deacetylase inhibitor, alters chromatin structure, potentially enhancing ZFHEP's access to DNA. This can indirectly increase ZFHEP's transcriptional regulatory activity. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine, a DNA methyltransferase inhibitor, alters DNA methylation patterns. This can enhance ZFHEP's transcriptional activity by changing the epigenetic landscape and accessibility of DNA. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin increases cAMP levels, which can enhance ZFHEP's transcriptional activity indirectly by modulating cAMP-responsive transcription factors that interact with ZFHEP in gene regulation. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG can modulate multiple signaling pathways, potentially enhancing ZFHEP activity by influencing pathways involved in cell differentiation and transcriptional regulation. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates Protein Kinase C (PKC), which can modulate transcription factors and signaling pathways interacting with ZFHEP, indirectly enhancing its transcriptional regulatory activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that can modify PI3K/AKT signaling pathways. This modification potentially enhances ZFHEP's transcriptional activity by affecting transcription factors and signaling networks in which ZFHEP is involved. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 inhibits MEK, which is involved in the MAPK/ERK pathway. This inhibition can indirectly enhance ZFHEP's role in transcriptional regulation by influencing the pathways and transcription factors interacting with ZFHEP. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor, potentially enhancing ZFHEP's transcriptional activity by modulating pathways that intersect with ZFHEP's regulatory functions in gene expression. | ||||||